A New Era for Embryo Screening: Juniper Genomics Debuts with World's First Whole-Genome and Transcriptome Test
Toronto, Ontario, June 26, 2025 (GLOBE NEWSWIRE) -- Juniper Genomics, a health-tech company pioneering a new standard of care in IVF, today announced its public launch alongside a $4.6 million seed round led by Company Ventures, with participation from Innospark Ventures, MBX Capital, Amboy Street Ventures, Dria Ventures, and Blue Collective. Founded by experts in genomics, reproductive medicine, and bioethics—Jeremy Grushcow, PhD, JD (CEO), Carolyn Quinlan, MSc (VP of Bioethics), and Dr. Lee Shulman (Medic ...